Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
OBJECTIVE
To assess the influence of alterations in glucose concentrations on androgen levels in patients with polycystic ovary syndrome (PCOS) and in healthy controls.


METHODS
Prospective, controlled study.


METHODS
Tertiary care center.


METHODS
Seven patients with PCOS and 20 healthy controls.


METHODS
Hyperinsulinemic glucose clamp study with stepwise reduction of the plasma glucose level from hyperglycemia to hypoglycemia.


METHODS
Concentrations of insulin, C-peptide, cortisol, T, androstenedione, 17-hydroxyprogesterone, DHEA, and DHEAS during hyperglycemia, euglycemia, and hypoglycemia.


RESULTS
Total T levels and the free androgen index were significantly higher in the PCOS group at baseline and throughout the clamp. The levels of T, androstenedione, DHEAS, and 17-hydroxyprogesterone were not influenced by short-term changes of plasma glucose concentrations in both groups. However, hypoglycemia led to a significant increase in DHEA levels in PCOS patients as well as in controls. Cortisol levels were not increased during hypoglycemia in either group.


CONCLUSIONS
In contrast to men, androgen levels are not influenced by short-term changes of plasma glucose levels in PCOS patients and in healthy women. However, DHEA concentrations increase with decreasing glucose levels independently from an activation of the hypothalamic-pituitary-adrenal axis. This supports a gender difference regarding the counterregulatory hormone response to hypoglycemia.
Ludwig
Annika K
AK
Center for Hormonal and Metabolic Disease, Reproductive Medicine, Gynecologic Endocrinology, and Prenatal Medicine, Endokrinologikum Hamburg, Lornsenstrasse 4-6, Hamburg, Germany. A.K.Ludwig@web.de
Goharian
Lilian G
LG
Dietze
Theresa
T
Tauchert
Sacha
S
Rudolf
Sebastian
S
Diedrich
Klaus
K
Schweiger
Ulrich
U
Oltmanns
Kerstin M
KM
D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000328:Adult; D000728:Androgens / Q000097:blood*; D000735:Androstenedione / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood; D003687:Dehydroepiandrosterone / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D015309:Glucose Clamp Technique; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood; D009765:Obesity / Q000097:blood* / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000150:complications; D011446:Prospective Studies; D012016:Reference Values; D013739:Testosterone / Q000097:blood; D049629:Waist-Hip Ratio; D055815:Young Adult
D000728:Androgens; D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D013739:Testosterone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate; D019326:17-alpha-Hydroxyprogesterone; D006854:Hydrocortisone